Name
HuC242-DMI/SB-408075 (cantuzumab mertasine)
Alternate Names
None
Abbreviations
None
Category
Chemotherapy
Subcategory
Monoclonal antibody combined with maytansinoid toxin
NSC Number
None
Primary Site
Histology
None
Remarks
Phase I/II Monoclonal antibody. ImmunoGen, GlaxoSmithKline.
Coding
This drug should be coded